Arbitrator Decisions
Claimant did not provide sufficient evidence to establish that the HCV Infected Person received a blood transfusion in Canada during the Class Period.
- #4 – April 15, 2021
- #6 – June 3, 2021
Negative traceback
Loss of Services
Non-prescription intravenous drug use
